GILD

The 3 Best Biotech Stocks to Buy in August

By Jeremy Flint, InvestorPlace Contributor
Even as healthcare stocks suffer from post-pandemic fatigue, these three of the best biotech stocks to buy and ride the wave of good news.

Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points

By Joel Baglole, InvestorPlace Contributor
Investors looking to give their portfolio a boost should consider one of these leading biotech names, which are undervalued right now.

The 7 Most Undervalued Nasdaq Stocks to Buy Now: July 2023

By Ian Bezek, InvestorPlace Contributor
The market is soaring, but there is still time to buy these seven undervalued Nasdaq stocks before they head higher.

The 3 Best Biotech Stocks to Buy In July

By Joel Baglole, InvestorPlace Contributor
With these companies fueling sales and earnings with medical innovations and breakthroughs, they may be the best biotech stocks to pick up.

How to Retire Rich: Biotech Stocks Edition

By Josh Enomoto, InvestorPlace Contributor
Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks.

3 Biotech Stocks That Could Skyrocket in the Next 12 Months

By Muslim Farooque, InvestorPlace Contributor
These promising biotech stocks are risky but offer tremendous upside generating stellar long-term returns in the upcoming 12 months.

3 Undervalued Biotech Stocks to Buy Before They Blast Off

By Chris Markoch, InvestorPlace Contributor
Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling.

3 Analyst Upgrades That Smart Investors Won’t Ignore

By Chris Markoch, InvestorPlace Contributor
Even the most experienced investors have only so many hours in the day to perform their due diligence. That’s where analyst ratings can be helpful.…

GILD Stock Price Predictions: Is Gilead Sciences Really Worth $100?

By William White, InvestorPlace Writer
Gilead Sciences (GILD) stock is a hot topic on Tuesday as a new price target predicts a roughly 28% upside for the shares.

3 Cash-Rich Biotech Stocks to Bet on for the Long Haul

By John Blankenhorn, InvestorPlace Contributor
Cash rich biotech stocks can survive while most of their peers struggle with rising interest rates. Here are three to watch.

Strong Quant Screens Say These 7 Growth Stocks Are a Buy

By Chris Lau, InvestorPlace Contributor
Stockrover’s quant screen is a grading system that brings up rewarding growth stocks to buy for income investors.

7 Cash-Rich Companies to Invest in During Economic Uncertainty

By Josh Enomoto, InvestorPlace Contributor
Although they’re not necessarily the most exciting enterprises, these cash-rich stocks should keep your portfolio upright.

7 Dividend Stocks to Buy and Hold Forever

By Will Ashworth, InvestorPlace Contributor
If you’re a dividend investor these seven dividend stocks to buy and hold forever are worth considering heading into 2023.

Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data

By Josh Enomoto, InvestorPlace Contributor
Although Gilead Sciences produced meaningful results regarding a lung cancer drug test, the competitive shortfall hurt GILD stock.

The 7 Best Retirement Stocks to Buy Now

By Louis Navellier and the InvestorPlace Research Staff
Current bear market conditions present the perfect opportunity to invest in retirement stocks while they're trading at bargain valuations.

Why Is Arcellx (ACLX) Stock Up 25% Today?

By David Moadel, InvestorPlace Contributor
ACLX stock is usually under the radar, but today it's in the spotlight as Arcellx reveals a team-up with a well-known biotech business.

7 Monthly Dividend Stocks to Buy for Safety

By Muslim Farooque, InvestorPlace Contributor
These safe monthly dividend stocks offer investors incredible dividend yields and healthy upside potential

Why Is Gilead Sciences (GILD) Stock Up Today?

By Bret Kenwell, InvestorPlace Contributor
Gilead Sciences has a low valuation, but no growth. Perhaps settling a patent lawsuit will help give GILD stock the boost it needs.

What Is Going on With Gilead Sciences (GILD) Stock Today?

By David Moadel, InvestorPlace Contributor
GILD stock is the focus of not just one but two news items today, and traders are trying to decide if they're bullish or bearish.
Load More